Postoperative complications and long-term survival among patients treated surgically for renal cell carcinoma
- PMID: 22114816
- DOI: 10.1016/j.juro.2011.09.031
Postoperative complications and long-term survival among patients treated surgically for renal cell carcinoma
Abstract
Purpose: In addition to their acute implications, adverse events after oncological surgery may have late or long-term consequences for patient outcomes. We assessed the relationship between postoperative complications and long-term survival among patients treated surgically for kidney cancer.
Materials and methods: Using Surveillance, Epidemiology and End Results-Medicare data we identified patients with kidney cancer treated surgically from 1995 through 2005. After excluding from analysis those who died during the index hospitalization or within 30 days of surgery we compared overall survival for patients with or without a postoperative complication. We then fit multivariate Cox proportional hazard models to estimate the association between complications and long-term survival, adjusting for patient characteristics, cancer severity and surgical approach.
Results: We identified 4,687 (37%) and 7,931 patients (63%) with and without a postoperative complication, respectively. During a median followup of 32 months (range 1 to 132) 3,425 patients (27.1%) died of any cause. Patients with at least 1 postoperative complication had lower unadjusted 5-year survival (59.9% vs 69.5%, p <0.001). On multivariate analyses the occurrence of a complication was also associated with significantly worse long-term survival (HR 1.24, 95% CI 1.16-1.33). This relationship was consistent with time, across surgical approaches and among patients with various specific complications, including acute renal failure, cardiac and neurological events, postoperative infection and sepsis.
Conclusions: The occurrence of a postoperative complication is associated with decreased long-term survival after surgery for kidney cancer. Clarification of the cascade of events underlying this relationship may lead to new strategies to improve outcomes among cancer survivors.
Copyright © 2012 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.
Comment in
-
Editorial comment.J Urol. 2012 Jan;187(1):66-7. doi: 10.1016/j.juro.2011.09.169. Epub 2011 Nov 23. J Urol. 2012. PMID: 22114819 No abstract available.
Similar articles
-
Prognostic factors influencing long-term survival of patients undergoing nephron-sparing surgery for nonmetastatic renal-cell carcinoma (RCC) with imperative indications.Ann Surg Oncol. 2010 Feb;17(2):544-51. doi: 10.1245/s10434-009-0812-y. Epub 2009 Dec 1. Ann Surg Oncol. 2010. PMID: 19953334
-
Long-term outcomes after nephron sparing surgery for renal cell carcinoma larger than 4 cm.J Urol. 2009 Jan;181(1):35-41. doi: 10.1016/j.juro.2008.09.025. Epub 2008 Nov 13. J Urol. 2009. PMID: 19012929
-
Partial nephrectomy for renal masses ≥ 7 cm: technical, oncological and functional outcomes.BJU Int. 2012 May;109(10):1450-6. doi: 10.1111/j.1464-410X.2011.10608.x. Epub 2012 Jan 5. BJU Int. 2012. PMID: 22221502
-
Renal cancer surgery in the elderly.Curr Opin Urol. 2009 Sep;19(5):459-64. doi: 10.1097/MOU.0b013e32832f0c7d. Curr Opin Urol. 2009. PMID: 19571755 Review.
-
Meta-analysis of the effect of postoperative in-hospital morbidity on long-term patient survival.Br J Surg. 2014 Nov;101(12):1499-508. doi: 10.1002/bjs.9615. Epub 2014 Aug 11. Br J Surg. 2014. PMID: 25132117 Review.
Cited by
-
Postoperative Complications Result in Poor Oncological Outcomes: What Is the Evidence?Curr Oncol. 2024 Aug 15;31(8):4632-4655. doi: 10.3390/curroncol31080346. Curr Oncol. 2024. PMID: 39195329 Free PMC article. Review.
-
Survival after minimally invasive vs. open radical nephrectomy for stage I and II renal cell carcinoma.Int J Clin Oncol. 2022 Jun;27(6):1068-1076. doi: 10.1007/s10147-022-02153-5. Epub 2022 Mar 23. Int J Clin Oncol. 2022. PMID: 35319076
-
Inhibition of LPS-mediated TLR4 activation abrogates gastric adenocarcinoma-associated peritoneal metastasis.Clin Exp Metastasis. 2022 Apr;39(2):323-333. doi: 10.1007/s10585-021-10133-8. Epub 2021 Nov 12. Clin Exp Metastasis. 2022. PMID: 34767138
-
Toll-like receptors: exploring their potential connection with post-operative infectious complications and cancer recurrence.Clin Exp Metastasis. 2020 Apr;37(2):225-239. doi: 10.1007/s10585-020-10018-2. Epub 2020 Jan 23. Clin Exp Metastasis. 2020. PMID: 31975313 Review.
-
Prognostic Implications of Postoperative Infectious Complications in Non-Small Cell Lung Cancer.Korean J Thorac Cardiovasc Surg. 2018 Feb;51(1):41-52. doi: 10.5090/kjtcs.2018.51.1.41. Epub 2018 Feb 5. Korean J Thorac Cardiovasc Surg. 2018. PMID: 29430428 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
